Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.56 USD | +3.56% | +12.59% | +58.74% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.74% | 2.45B | |
+75.34% | 12.38B | |
-20.33% | 7.76B | |
+7.06% | 6.61B | |
+12.78% | 5.4B | |
+37.02% | 4.96B | |
-17.50% | 4.75B | |
-24.72% | 3.89B | |
-27.89% | 2.66B | |
+2.60% | 1.98B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited, Q1 2023 Earnings Call, May 04, 2023